SlideShare une entreprise Scribd logo
1  sur  194
Nephrology Review February 19, 2010
RENAL FUNCTION ,[object Object],[object Object],[object Object],END PRODUCTS DRUGS TOXINS FLUID ELECTROLYTES OSMOLARITY ACID-BASE RENIN ERYTHROPOIETIN 1,25(OH) 2 VIT.D3 Briggs JP, Schnermann JB. Primer on KIDNEY DISEASES. 2nd ed. 1998
GFR ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Milutinovic et al. Kidney Int. 1975:8;185-190 inulin iothalamate (CCr+Curea)/2
Na + K + Cl -
Tubular function ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
การที่มี  BUN  และ  serum creatinine  สูงเกินค่าปกติ   (Normal Cr  ชาย  ≤   1.5,  หญิง   ≤   1.3 mg/dl)  Azotemia
Uremia กลุ่มอาการที่เกิดจากความผิดปกติของการคั่งของของเสีย สารน้ำและเกลือแร่ที่เกิดคู่กับการเสื่อมหน้าที่ของไต - nausea, vomiting - anorexia - weight loss - dyspnea - fatigue - pruritus
Azotemia GFR   ปกติ GFR   ต่ำ Acute KI Chronic KD Intrinsic RF Post RF Pre RF Chronic GN Chronic TIN BUN  Cr
Normal GFR ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Decrease GFR ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Acute Renal Failure (ARF)  Acute Kidney Injury (AKI) ,[object Object],[object Object],[object Object]
Definition of Acute kidney injury OR 2004 Level of  dysfunciton Outcome
 
Acute Kidney Injury Within 48 hours  serum Cr > 0.3 mg/dL  serum Cr > 50% (1.5 fold) More than 6 hours  urine output < 0.5 ml/kg/hr  Adequate fluid resuscitation
AKIN classification   Baseline serum Cr (48 hr)   urine output Stage 1 (R)  >0.3 mg/dL or   1.5-2 fold  <0.5 mL/kg/hr >6 hr Stage 2 (I)  2-3 fold  <0.5 mL/kg/hr >12 hr Stage 3 (F)  >3 fold or  <0.3 mL/kg/hr >24 hr  >0.5 mg/dL if Cr > 4 mg/dL)  anuria for 12 hr RRT No GFR criteria
 
Decreased circulatory volume Activation of central baroreceptors Norepinephrine Vasopressin Angiotensin II PGE2 / PGI2 Nitric oxide Autoregulation (MAP > 70) Vasoconstriction Mesangial contraction Reduced renal blood flow & GFR Prerenal
Renal causes ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Functional & Physiologic change Loss of cell polarity Loss Cell-cell, cell matrix interaction Tight junction  defect ↑  Distal Na delivery Tubular obstruction Back leak Renal vasoconstriction ↓ GFR Tubuloglomerular feedback Brush border detachment
Pre-renal VS Renal ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],=  UNa  PCr    100   PNa  UCr FE Na (%) RFI
Na + K + Cl - Medullary ischemia Intermediate syndrome Urine Na low Urine spgr low
Risk of aminoglycosides nephrotoxic  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Amphotericin B ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cisplatin ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Radiocontrast nephropathy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Acute renal failure ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Investigation ,[object Object],[object Object],[object Object],[object Object],[object Object]
Management ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
CAUSES OF ANEMIA IN CRF ,[object Object],[object Object],[object Object],[object Object],[object Object],Schrier RW, Gottschalk CW. Diseases of the kidney. 6th ed. Vol.III, 1996. Fe   ,  Folate , B1, B6, B12 Mild hemolysis :  ↓ Na-K-ATPase activity sensitive to oxidants ,  dialysis Factors?, PTH, Al
RENAL OSTEODYSTROPHY ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Hypocalcemia Hyperphosphatemia Low vitamin D Bone resistance
Comprehensive strategy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Med Clin N Am 89 (2005) 489–509
RENAL Na +  REABSORPTION HCO 3 - HCO 3 -  + H 2 O+CO 2 CA H +  +HCO 3 - CA Na + glucose PO 4 AA Carbonic anhydrase inhibitor H + Na + 3 HCO 3 - Na + 3Na + 2K + 3Na + 2K + 3HCO 3 - Na +
TAL of Henle Loop diuretics
DISTAL TUBULE Thiazide
CORTICAL COLLECTING TUBULE Na + K + H + spironolactone Amiloride
POLYURIA
DEFINITION ,[object Object],[object Object],[object Object],[object Object],[object Object]
What is urine? ,[object Object],[object Object]
   GFR    salt excretion    H 2 O excretion
Polyuria ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Central DI ,[object Object],[object Object],[object Object]
Nephrogenic DI ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Water reabsorption V2 Medullary Hypertonicity
Approach ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Approach ,[object Object],[object Object],[object Object],[object Object]
Approach ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
CAUSES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Water diuresis ,[object Object],[object Object],[object Object],[object Object],[object Object]
Gestational DI ,[object Object],[object Object],[object Object],[object Object]
Primary polydipsia ,[object Object],[object Object],[object Object],[object Object],[object Object]
Water deprivation test ,[object Object],[object Object],[object Object],[object Object]
ADH stimulation Central Nephrogenic Partial Complete
Water Deprivation Test ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Solute diuresis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Solute diuresis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],} > 250 mmol/L
Fluid therapy
hypotonic isotonic colloid ICF 2/3 ECF 1/3 II 3/4 IV 1/4 TBW  - male : 60%BW, Female 50%BW Elder - male : 50%BW, Female 45%BW Children  : 60%BW
HYPERTONIC SALINE ,[object Object],[object Object],[object Object],[object Object],[object Object],! Benefit in head injured patients ! Arch Surg 1993;128
Bunn F, Trivedi D, Ashraf S. Colloid solutions for fluid resuscitation.  Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD001319. DOI: 10.1002/14651858.CD001319.pub2. There is no evidence that one colloid solution is  more effective or safe than any others  (albumin, PPF, dextran, HES, gelatin) There is no evidence from RCTs that resuscitation  with colloids reduces the risk of death, compared  to resuscitation with crystalloids,in patients with  trauma, burns or following surgery. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients.  Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD000567. DOI: 10.1002/14651858.CD000567.pub3.
Fluid therapy ,[object Object],[object Object],[object Object],[object Object],[object Object]
SUMMARY ,[object Object],[object Object],[object Object],[object Object],[object Object]
Water balance
Hyponatremia  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],No corrected formula for any serum glucose level
Management hyponatremia ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
 
Potassium
K BALANCE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
50 – 55 mEq/kg 3,000 – 4,000 mEq 65 mEq (2%) Red cell 250 mEq Muscle 2,635 mEq Liver 250 mEq  Bone 300 mEq ICF ECF II IV K 160mEq/l K 4mEq/l 5-10 mEq 5-10 mEq 50-100 mEq 90-95  mEq
 
100% 25% 10% 25% 20% ,[object Object],[object Object],[object Object]
HYPOKALEMIA
DEFINITION ,[object Object]
DIAGNOSIS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
SIGNS & SYMPTOMS ,[object Object],[object Object],[object Object],[object Object],[object Object]
ST depress, Peak P, PR prolong Widening QRS
CAUSES ,[object Object],[object Object],[object Object],[object Object]
Hypokalemia [acid-base, ECF volume, hypertension, urine K + ] Metabolic acidosis urine K +   low    high (urine Na+ > 100 mEq/day) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Metabolic alkalosis urine K +   low    high (urine Na +  > 100 mEq/day) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],normotension   hypertension ,[object Object],[object Object],Normal acid-base ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Urine pH < 5.5    diarrhea   > 5.5    urine net charge   -ve    diarrhea   +ve    RTA
Hypokalemia, Hypertension, Metabolic alkalosis, renal K +  loss (screening test) [plasma renin activity (PRAng/ml/hr), plasma aldosterone concentration (PAC,ng/dl)] ↑  PRA   ↓ PRA (<1)  ↓ PRA  ↑  PAC   ↑ PAC ( > 9)     ↓ PAC  PAC/PRA ~10   > 50   24 hr urine aldosterone >14    g   < 20 exclude ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Algorithm ,[object Object],[object Object],[object Object],[object Object],[object Object]
TTKG ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],+
Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
HYPERKALEMIA
DIAGNOSIS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Flat P Prolong PR AV block Widening QRS Sine-wave
CAUSES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
DIAGNOSIS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
TREATMENT ,[object Object],[object Object],[object Object],[object Object],[object Object]
TREATMENT ,[object Object],[object Object],[object Object],[object Object]
SPECIFIC TREATMENT ,[object Object],[object Object],[object Object]
 
Intracellular K +  shift ,[object Object],[object Object],[object Object]
Remove K + ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
TREATMENT   mechanism   onset  peak Ca  antagonist   1-5 min   HD  remove   15 min PD  remove   2 h Kay exalate  remove   1-6 h NaHCO 3  shift   unreliable Insulin  shift   1 0 - 2 0 min   1-2 h B2 agonist  shift   1 0 - 20  min   1-2 h
ADJUNCTIVE TREATMENT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Acid-Base Disorders
DEFINITION ,[object Object],[object Object],[object Object],[object Object],[object Object],Clinical &  Arterial blood gas
PCO 2 H + , HCO 3 - HCO 3 - /CO 2 Albumin Bone Proteins PO 4 Buffers
 
REMEMBER ,[object Object],[object Object],[object Object],[object Object],PCO 2 H + , HCO 3 -
Normal  meat-based  Diet ,[object Object],[object Object]
KIDNEYS ,[object Object],[object Object],[object Object],[object Object]
COMPENSATORY RESPONSE [ACIDOSIS] ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
COMPENSATORY RESPONSE [ALKALOSIS] ,[object Object],[object Object],[object Object],[object Object],[object Object]
 
ASSESSMENT OF ACID-BASE DISORDER ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Hypoventilation
Hyperventilation
Causes of  metabolic acidosis
H + X -   -> H + X -   ->   CO 2  + NaX   ->  Kidney   ->   + HCO 3 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],H +  : TA,  NH 4 + NaX
[object Object],[object Object],[object Object],SERUM ANION GAP ( Albumin , phosphate, sulphate, organic anion) – (K + , Mg 2+ , Ca 2+ ) = 12 HA   H +   +  A - 1 g/dL = 2.5 - 3 mEq/L
H + X -   -> H + X -   ->   CO 2  + NaX   ->  Kidney   -> H + X -   + Na HCO 3 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Wide anion gap Normal anion gap
H + X -   -> H + X -   ->   CO 2  + NaX   ->  Kidney   -> H + X -   + Na HCO 3 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Wide anion gap Normal anion gap Poor tissue perfusion     serum lactate > 5 mmol/l DKA, alcolhol     serum ketone Methanol, ethylene glycol     serum osmolol gap > 25  Urine NH 4 +     urine net charge    (Na +  + K + ) - Cl -
Mixed wide & normal gap acidosis ,[object Object],[object Object],[object Object],[object Object],[object Object]
TREATMENT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
CAUSES OF METABOLIC ALKALOSIS (Generation) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Renal HCO 3 -   reabsorption Serum  HCO 3 -   (mEq/l) HCO 3 -   reabsorption 25   50 Volume depletion K +  depletion
Assessment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
CAUSES OF METABOLIC ALKALOSIS (Generation) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Volume depletion, ↓ urine Cl - Hypertension, ↑ urine Cl - Volume depletion, ↓ urine Cl -
CAUSES OF METABOLIC ALKALOSIS ,[object Object],[object Object],[object Object],[object Object],Treatment
TREATMENT ,[object Object],[object Object],[object Object],[object Object]
Approach to Patients with Glomerular Diseases Suchai Sritippayawan Division of Nephrology , Internal Medicine, Siriraj Hospital, Mahidol University
Structure
pore fenestration charge Slit pore
Pathogenesis
JOURNAL OF NEPHROLOGY Vol .  11 No .  4  -  1998  /  177-182
 
Structure Proliferation Expansion  Endocap-proliferation Thinkening : spike, double contour Necrosis Leucocytic infiltration  Extracap-proliferation  (crescent)  vasculitis
Mesangial : IgMN, IgAN, lupus Subepithelial : membranous Subendothelial : lupus Intra GBM : lupus, MPGN I
Brenner :  Brenner and Rector's The Kidney,  8th ed. Copyright ©  2007 Saunders, An Imprint of Elsevier
Clinical features ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical syndromes ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Asymtomatic hematuria  ,[object Object],[object Object],[object Object],[object Object],[object Object]
>70% of RC are glomerular RC Proteinuria > 1 g/day   or 2+ Indetermine 30–70% Nonglom. <30% acanthocyte ring
Proteinuria ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Types of proteinuria (pathophysiology) ,[object Object],[object Object],[object Object],[object Object]
Asymptomatic proteinuria ,[object Object],[object Object],[object Object],[object Object]
Nephrotic syndrome ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Nephrotic syndrome ,[object Object],[object Object],[object Object]
 
Nephritic syndrome ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
Rapidly progressive GN (RPGN) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Telescopic urine sediment
How to approach?
[object Object],[object Object],[object Object],[object Object],[object Object]
Secondary  glomerular diseases
Secondary  glomerular diseases ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Secondary  glomerular diseases ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Metabolic disorders ,[object Object],[object Object]
Diabetic nephropathy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Diabetic nephropathy ,[object Object],[object Object],[object Object],[object Object],[object Object]
DM & glomerular diseases ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Collagen vascular diseases autoimmune disease ,[object Object],[object Object],[object Object],[object Object],[object Object]
Ig deposition diseases ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Infections  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Drugs ,[object Object],[object Object]
Malignancy  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Others  ,[object Object]
Primary  glomerular diseases
Primary glomerular diseases ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Investigations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Kidney biopsy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Individual investigations ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Managements
Managements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Managements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Managements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
IgA nephropathy ,[object Object],[object Object],[object Object],[object Object],[object Object]
Lupus nephritis   :  Siriraj experience ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Lupus nephritis treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
PREGNANCY  &  KIDNEY DISEASE
NORMAL PHYSIOLOGY ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
RENAL FUNCTIONS ,[object Object],[object Object],[object Object],[object Object]
ELECTROLYTES & ACID-BASE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Sheehan’s Nephrogenic DI Acute fatty liver (central DI)
HYPERTENSION ,[object Object],[object Object],[object Object],[object Object]
DEFINITION ,[object Object],[object Object],[object Object],[object Object]
DIFFERENTIAL DIAGNOSIS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Gradual onset HT Proteinuria edema
ACUTE RENAL FAILURE ,[object Object],[object Object],[object Object]
  HELLP  acute fatty live HUS,TTP Onset > 20 wk      < 20 wk < 48 hr PPT      > 48 hr PPT Plt        Coag   DIC DIC   normal Liver dysfn          normal  hypoglycemia Renal failure  mild              
ACUTE RENAL FAILURE ,[object Object],[object Object],[object Object],[object Object]
PREGNANCY    RENAL DIS. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],RENAL DIS.    PREGNANCY
TERMINATION OF PREGNANCY ,[object Object],[object Object],[object Object]
TREATMENT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ANTIHYPERTENSIVE ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Contenu connexe

Tendances

Pharmacotherapy of renal failure
Pharmacotherapy of renal  failurePharmacotherapy of renal  failure
Pharmacotherapy of renal failureMuhammed Rashid Ak
 
Alcoholic Hepatitis & Hepatorenal Syndrome
Alcoholic Hepatitis & Hepatorenal SyndromeAlcoholic Hepatitis & Hepatorenal Syndrome
Alcoholic Hepatitis & Hepatorenal SyndromeAbdul Hamid Alraiyes
 
Lab diagnosis in renal diseases
Lab diagnosis in renal diseasesLab diagnosis in renal diseases
Lab diagnosis in renal diseasesMeghana P
 
Endocrine disorders in chronic kidney disease
Endocrine disorders in chronic kidney diseaseEndocrine disorders in chronic kidney disease
Endocrine disorders in chronic kidney diseaseDr. Lala Shourav Das
 
Chronic Kidney Disease: Diagnosis and management
Chronic Kidney Disease: Diagnosis and managementChronic Kidney Disease: Diagnosis and management
Chronic Kidney Disease: Diagnosis and managementkkcsc
 
End stage renal failure
End stage renal failureEnd stage renal failure
End stage renal failurermhaupert
 
Pediatric Chronic kidney disease
Pediatric Chronic kidney diseasePediatric Chronic kidney disease
Pediatric Chronic kidney diseaseDeepshikha Singh
 
Ckd prevention
Ckd preventionCkd prevention
Ckd preventiondarsh 1980
 
Chronic renal failure update on diagnostic tests
Chronic renal failure update on diagnostic testsChronic renal failure update on diagnostic tests
Chronic renal failure update on diagnostic testsDr. Rajesh Bendre
 
Acute Kidney Injury - Pediatric Perspective
Acute Kidney Injury - Pediatric PerspectiveAcute Kidney Injury - Pediatric Perspective
Acute Kidney Injury - Pediatric PerspectiveSourabh Gupta
 
Diagnosis & medical management of ckd
Diagnosis & medical management of ckdDiagnosis & medical management of ckd
Diagnosis & medical management of ckdKavinda Theekshana
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failureSuresh Gorka
 
Chronic kidney disease
Chronic kidney diseaseChronic kidney disease
Chronic kidney diseasedrblack8
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failureVijay Yadav
 
Management of chronic kidney disease
Management of chronic kidney diseaseManagement of chronic kidney disease
Management of chronic kidney diseaseShivshankar Badole
 

Tendances (20)

Pharmacotherapy of renal failure
Pharmacotherapy of renal  failurePharmacotherapy of renal  failure
Pharmacotherapy of renal failure
 
Alcoholic Hepatitis & Hepatorenal Syndrome
Alcoholic Hepatitis & Hepatorenal SyndromeAlcoholic Hepatitis & Hepatorenal Syndrome
Alcoholic Hepatitis & Hepatorenal Syndrome
 
Lab diagnosis in renal diseases
Lab diagnosis in renal diseasesLab diagnosis in renal diseases
Lab diagnosis in renal diseases
 
Endocrine disorders in chronic kidney disease
Endocrine disorders in chronic kidney diseaseEndocrine disorders in chronic kidney disease
Endocrine disorders in chronic kidney disease
 
Chronic Kidney Disease: Diagnosis and management
Chronic Kidney Disease: Diagnosis and managementChronic Kidney Disease: Diagnosis and management
Chronic Kidney Disease: Diagnosis and management
 
End stage renal failure
End stage renal failureEnd stage renal failure
End stage renal failure
 
Pediatric Chronic kidney disease
Pediatric Chronic kidney diseasePediatric Chronic kidney disease
Pediatric Chronic kidney disease
 
CKD Case Study
CKD Case StudyCKD Case Study
CKD Case Study
 
Ckd prevention
Ckd preventionCkd prevention
Ckd prevention
 
Chronic renal failure update on diagnostic tests
Chronic renal failure update on diagnostic testsChronic renal failure update on diagnostic tests
Chronic renal failure update on diagnostic tests
 
Diabetic kidney disease 2021
Diabetic kidney disease 2021Diabetic kidney disease 2021
Diabetic kidney disease 2021
 
A Case of Acute Kidney Injury (ARF)
A Case of Acute Kidney Injury (ARF)A Case of Acute Kidney Injury (ARF)
A Case of Acute Kidney Injury (ARF)
 
Acute Kidney Injury - Pediatric Perspective
Acute Kidney Injury - Pediatric PerspectiveAcute Kidney Injury - Pediatric Perspective
Acute Kidney Injury - Pediatric Perspective
 
Diagnosis & medical management of ckd
Diagnosis & medical management of ckdDiagnosis & medical management of ckd
Diagnosis & medical management of ckd
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
 
Chronic kidney disease
Chronic kidney diseaseChronic kidney disease
Chronic kidney disease
 
Diuretics in CKD
Diuretics in CKDDiuretics in CKD
Diuretics in CKD
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
 
Management of chronic kidney disease
Management of chronic kidney diseaseManagement of chronic kidney disease
Management of chronic kidney disease
 
Ckd 2016 100 2
Ckd 2016 100 2Ckd 2016 100 2
Ckd 2016 100 2
 

En vedette

Compre si 2010 l
Compre si 2010 lCompre si 2010 l
Compre si 2010 lvora kun
 
NT step2 march 53
NT step2 march 53NT step2 march 53
NT step2 march 53vora kun
 
ortho 02 orthopaedic complication & prevention + orthopaedic trauma (practica...
ortho 02 orthopaedic complication & prevention + orthopaedic trauma (practica...ortho 02 orthopaedic complication & prevention + orthopaedic trauma (practica...
ortho 02 orthopaedic complication & prevention + orthopaedic trauma (practica...vora kun
 
CPR 2010 อ ปริญญา รามา
CPR 2010 อ ปริญญา รามาCPR 2010 อ ปริญญา รามา
CPR 2010 อ ปริญญา รามาvora kun
 
Mdcu Preventive Screening
Mdcu Preventive ScreeningMdcu Preventive Screening
Mdcu Preventive Screeningvora kun
 
Endocrine Med 2010 Step2
Endocrine Med 2010 Step2Endocrine Med 2010 Step2
Endocrine Med 2010 Step2vora kun
 
Diabetic mellitus 02
Diabetic mellitus 02Diabetic mellitus 02
Diabetic mellitus 02vora kun
 
NeuroSx step2 Review
NeuroSx step2 ReviewNeuroSx step2 Review
NeuroSx step2 Reviewvora kun
 
Compre Rama 2010
Compre Rama 2010Compre Rama 2010
Compre Rama 2010vora kun
 
Nt2009 complete all
Nt2009 complete allNt2009 complete all
Nt2009 complete allvora kun
 
ortho 06 common ortho dis 2 edited 12 mar 10
ortho 06 common ortho dis 2 edited 12 mar 10ortho 06 common ortho dis 2 edited 12 mar 10
ortho 06 common ortho dis 2 edited 12 mar 10vora kun
 
Step3 Tutorial by SWU book2
Step3 Tutorial by SWU book2Step3 Tutorial by SWU book2
Step3 Tutorial by SWU book2vora kun
 
Abnormal pap smear ศิริราช ppt
Abnormal pap smear ศิริราช pptAbnormal pap smear ศิริราช ppt
Abnormal pap smear ศิริราช pptvora kun
 
ortho 02 orthopaedic complication & prevention + orthopaedic trauma (practica...
ortho 02 orthopaedic complication & prevention + orthopaedic trauma (practica...ortho 02 orthopaedic complication & prevention + orthopaedic trauma (practica...
ortho 02 orthopaedic complication & prevention + orthopaedic trauma (practica...vora kun
 
History taking-and-physical-examination-in-newborn-and 11072011
History taking-and-physical-examination-in-newborn-and 11072011History taking-and-physical-examination-in-newborn-and 11072011
History taking-and-physical-examination-in-newborn-and 11072011Dong Dang
 
ประกาศรับสมัคร พยาบาลวิชาชีพ แพทย์ไทย พนักงานพิมพ์
ประกาศรับสมัคร พยาบาลวิชาชีพ แพทย์ไทย พนักงานพิมพ์ประกาศรับสมัคร พยาบาลวิชาชีพ แพทย์ไทย พนักงานพิมพ์
ประกาศรับสมัคร พยาบาลวิชาชีพ แพทย์ไทย พนักงานพิมพ์Aiman Sadeeyamu
 
New born-assessmente
New born-assessmente New born-assessmente
New born-assessmente Dong Dang
 

En vedette (20)

An intresting case of quadriparesis
An intresting case of quadriparesisAn intresting case of quadriparesis
An intresting case of quadriparesis
 
Compre si 2010 l
Compre si 2010 lCompre si 2010 l
Compre si 2010 l
 
Swu
SwuSwu
Swu
 
NT step2 march 53
NT step2 march 53NT step2 march 53
NT step2 march 53
 
ortho 02 orthopaedic complication & prevention + orthopaedic trauma (practica...
ortho 02 orthopaedic complication & prevention + orthopaedic trauma (practica...ortho 02 orthopaedic complication & prevention + orthopaedic trauma (practica...
ortho 02 orthopaedic complication & prevention + orthopaedic trauma (practica...
 
CPR 2010 อ ปริญญา รามา
CPR 2010 อ ปริญญา รามาCPR 2010 อ ปริญญา รามา
CPR 2010 อ ปริญญา รามา
 
Mdcu Preventive Screening
Mdcu Preventive ScreeningMdcu Preventive Screening
Mdcu Preventive Screening
 
Endocrine Med 2010 Step2
Endocrine Med 2010 Step2Endocrine Med 2010 Step2
Endocrine Med 2010 Step2
 
Diabetic mellitus 02
Diabetic mellitus 02Diabetic mellitus 02
Diabetic mellitus 02
 
NeuroSx step2 Review
NeuroSx step2 ReviewNeuroSx step2 Review
NeuroSx step2 Review
 
Compre Rama 2010
Compre Rama 2010Compre Rama 2010
Compre Rama 2010
 
Nt2009 complete all
Nt2009 complete allNt2009 complete all
Nt2009 complete all
 
ortho 06 common ortho dis 2 edited 12 mar 10
ortho 06 common ortho dis 2 edited 12 mar 10ortho 06 common ortho dis 2 edited 12 mar 10
ortho 06 common ortho dis 2 edited 12 mar 10
 
Step3 Tutorial by SWU book2
Step3 Tutorial by SWU book2Step3 Tutorial by SWU book2
Step3 Tutorial by SWU book2
 
Abnormal pap smear ศิริราช ppt
Abnormal pap smear ศิริราช pptAbnormal pap smear ศิริราช ppt
Abnormal pap smear ศิริราช ppt
 
Electrolytes disorders
Electrolytes disordersElectrolytes disorders
Electrolytes disorders
 
ortho 02 orthopaedic complication & prevention + orthopaedic trauma (practica...
ortho 02 orthopaedic complication & prevention + orthopaedic trauma (practica...ortho 02 orthopaedic complication & prevention + orthopaedic trauma (practica...
ortho 02 orthopaedic complication & prevention + orthopaedic trauma (practica...
 
History taking-and-physical-examination-in-newborn-and 11072011
History taking-and-physical-examination-in-newborn-and 11072011History taking-and-physical-examination-in-newborn-and 11072011
History taking-and-physical-examination-in-newborn-and 11072011
 
ประกาศรับสมัคร พยาบาลวิชาชีพ แพทย์ไทย พนักงานพิมพ์
ประกาศรับสมัคร พยาบาลวิชาชีพ แพทย์ไทย พนักงานพิมพ์ประกาศรับสมัคร พยาบาลวิชาชีพ แพทย์ไทย พนักงานพิมพ์
ประกาศรับสมัคร พยาบาลวิชาชีพ แพทย์ไทย พนักงานพิมพ์
 
New born-assessmente
New born-assessmente New born-assessmente
New born-assessmente
 

Similaire à Tutorial national board 2010 Nephrology

Body fluid & electrolytes........Dr.Muhammad Anwarul Kabir,FCPS(Medicine)
Body fluid & electrolytes........Dr.Muhammad Anwarul Kabir,FCPS(Medicine)Body fluid & electrolytes........Dr.Muhammad Anwarul Kabir,FCPS(Medicine)
Body fluid & electrolytes........Dr.Muhammad Anwarul Kabir,FCPS(Medicine)kabirshiplu
 
Disorder of ca metabolism
Disorder of ca metabolismDisorder of ca metabolism
Disorder of ca metabolismAnaestHSNZ
 
Fluids and Electrolytes Basics
Fluids and Electrolytes BasicsFluids and Electrolytes Basics
Fluids and Electrolytes BasicsAlric Mondragon
 
A new perspective on hypokalemia
A new perspective on hypokalemiaA new perspective on hypokalemia
A new perspective on hypokalemiaSteve Chen
 
Electrolyte disorder
Electrolyte disorderElectrolyte disorder
Electrolyte disorderAshiqur Papel
 
13 Evaluation And Management Of Acute Renal Failure
13 Evaluation And Management Of Acute Renal Failure13 Evaluation And Management Of Acute Renal Failure
13 Evaluation And Management Of Acute Renal FailureDang Thanh Tuan
 
23 renal disease
23 renal disease23 renal disease
23 renal diseaseinternalmed
 
Serum Electrolytes.pptx
Serum Electrolytes.pptxSerum Electrolytes.pptx
Serum Electrolytes.pptxsimerakeno
 
11 Turman Management Of Acute Renal Failure In Picu
11 Turman   Management Of Acute Renal Failure In Picu11 Turman   Management Of Acute Renal Failure In Picu
11 Turman Management Of Acute Renal Failure In PicuDang Thanh Tuan
 
nur_4206--renal__updated_3-31-09.ppt
nur_4206--renal__updated_3-31-09.pptnur_4206--renal__updated_3-31-09.ppt
nur_4206--renal__updated_3-31-09.pptAmirAhmedGeza
 
Acute renal failure patho physiology & anaesthetic management
Acute renal failure patho physiology & anaesthetic managementAcute renal failure patho physiology & anaesthetic management
Acute renal failure patho physiology & anaesthetic managementdrriyas03
 
Approach to hyponatremia
Approach to hyponatremiaApproach to hyponatremia
Approach to hyponatremiamahendra maske
 
Renal system
Renal systemRenal system
Renal systemAji Kumar
 
A new perspective on hypokalemia
A new perspective on hypokalemiaA new perspective on hypokalemia
A new perspective on hypokalemiastevechendoc
 
Disorders of electrolyte balance: an overview
Disorders of electrolyte balance: an overviewDisorders of electrolyte balance: an overview
Disorders of electrolyte balance: an overviewSouvik Maitra
 

Similaire à Tutorial national board 2010 Nephrology (20)

Pccn Review Part 2
Pccn Review Part 2Pccn Review Part 2
Pccn Review Part 2
 
Group 3
Group 3Group 3
Group 3
 
Group 3
Group 3Group 3
Group 3
 
Body fluid & electrolytes........Dr.Muhammad Anwarul Kabir,FCPS(Medicine)
Body fluid & electrolytes........Dr.Muhammad Anwarul Kabir,FCPS(Medicine)Body fluid & electrolytes........Dr.Muhammad Anwarul Kabir,FCPS(Medicine)
Body fluid & electrolytes........Dr.Muhammad Anwarul Kabir,FCPS(Medicine)
 
Disorder of ca metabolism
Disorder of ca metabolismDisorder of ca metabolism
Disorder of ca metabolism
 
Fluids and Electrolytes Basics
Fluids and Electrolytes BasicsFluids and Electrolytes Basics
Fluids and Electrolytes Basics
 
A new perspective on hypokalemia
A new perspective on hypokalemiaA new perspective on hypokalemia
A new perspective on hypokalemia
 
Electrolyte disorder
Electrolyte disorderElectrolyte disorder
Electrolyte disorder
 
13 Evaluation And Management Of Acute Renal Failure
13 Evaluation And Management Of Acute Renal Failure13 Evaluation And Management Of Acute Renal Failure
13 Evaluation And Management Of Acute Renal Failure
 
A Case of Gitelman's Syndrome
A Case of Gitelman's SyndromeA Case of Gitelman's Syndrome
A Case of Gitelman's Syndrome
 
23 renal disease
23 renal disease23 renal disease
23 renal disease
 
CME: Acute Renal failure
CME: Acute Renal failureCME: Acute Renal failure
CME: Acute Renal failure
 
Serum Electrolytes.pptx
Serum Electrolytes.pptxSerum Electrolytes.pptx
Serum Electrolytes.pptx
 
11 Turman Management Of Acute Renal Failure In Picu
11 Turman   Management Of Acute Renal Failure In Picu11 Turman   Management Of Acute Renal Failure In Picu
11 Turman Management Of Acute Renal Failure In Picu
 
nur_4206--renal__updated_3-31-09.ppt
nur_4206--renal__updated_3-31-09.pptnur_4206--renal__updated_3-31-09.ppt
nur_4206--renal__updated_3-31-09.ppt
 
Acute renal failure patho physiology & anaesthetic management
Acute renal failure patho physiology & anaesthetic managementAcute renal failure patho physiology & anaesthetic management
Acute renal failure patho physiology & anaesthetic management
 
Approach to hyponatremia
Approach to hyponatremiaApproach to hyponatremia
Approach to hyponatremia
 
Renal system
Renal systemRenal system
Renal system
 
A new perspective on hypokalemia
A new perspective on hypokalemiaA new perspective on hypokalemia
A new perspective on hypokalemia
 
Disorders of electrolyte balance: an overview
Disorders of electrolyte balance: an overviewDisorders of electrolyte balance: an overview
Disorders of electrolyte balance: an overview
 

Plus de vora kun

NTstep3round2 9_jan2554
NTstep3round2 9_jan2554NTstep3round2 9_jan2554
NTstep3round2 9_jan2554vora kun
 
Osce examination si116
Osce examination si116Osce examination si116
Osce examination si116vora kun
 
ประชุมวิชาการ ศิริราช 53
ประชุมวิชาการ ศิริราช 53ประชุมวิชาการ ศิริราช 53
ประชุมวิชาการ ศิริราช 53vora kun
 
ประชุมวิชาการ ศิริราช 52
ประชุมวิชาการ ศิริราช 52ประชุมวิชาการ ศิริราช 52
ประชุมวิชาการ ศิริราช 52vora kun
 
Nt2553step3round1 28NOV2553
Nt2553step3round1 28NOV2553Nt2553step3round1 28NOV2553
Nt2553step3round1 28NOV2553vora kun
 
Osce ศรว ครั้งที่สอง 10jan53
Osce ศรว ครั้งที่สอง 10jan53Osce ศรว ครั้งที่สอง 10jan53
Osce ศรว ครั้งที่สอง 10jan53vora kun
 
Osce คณะ si 115
Osce คณะ si 115Osce คณะ si 115
Osce คณะ si 115vora kun
 
Osce ศรว ครั้งแรก dec52
Osce ศรว ครั้งแรก dec52Osce ศรว ครั้งแรก dec52
Osce ศรว ครั้งแรก dec52vora kun
 
Thai Osteoporosis guideline 2553
Thai Osteoporosis guideline 2553Thai Osteoporosis guideline 2553
Thai Osteoporosis guideline 2553vora kun
 
ortho 05 common rheumatic dx rx
ortho 05 common rheumatic dx rxortho 05 common rheumatic dx rx
ortho 05 common rheumatic dx rxvora kun
 
ortho 01 management of open fracture-update by kk 31052010
ortho 01 management of open fracture-update by kk 31052010ortho 01 management of open fracture-update by kk 31052010
ortho 01 management of open fracture-update by kk 31052010vora kun
 
ortho 04 drugs in orthopaedic (principle & common use)
ortho 04 drugs in orthopaedic (principle & common use)ortho 04 drugs in orthopaedic (principle & common use)
ortho 04 drugs in orthopaedic (principle & common use)vora kun
 
ortho 03 principle of closed reduction in fracture and dislocation
ortho 03 principle of closed reduction in fracture and dislocationortho 03 principle of closed reduction in fracture and dislocation
ortho 03 principle of closed reduction in fracture and dislocationvora kun
 
หัตถการที่จำเป็นทางสูติ
หัตถการที่จำเป็นทางสูติหัตถการที่จำเป็นทางสูติ
หัตถการที่จำเป็นทางสูติvora kun
 
SWU CXR interpretation
SWU  CXR interpretationSWU  CXR interpretation
SWU CXR interpretationvora kun
 
Step3 Tutorial by SWU book1
Step3 Tutorial by SWU book1Step3 Tutorial by SWU book1
Step3 Tutorial by SWU book1vora kun
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutritionvora kun
 
ศรว 51 By Cmu
ศรว 51 By Cmuศรว 51 By Cmu
ศรว 51 By Cmuvora kun
 
ศรว 51 ANS By Cmu
ศรว 51 ANS By Cmuศรว 51 ANS By Cmu
ศรว 51 ANS By Cmuvora kun
 
Nt2009 Complete Ans
Nt2009 Complete AnsNt2009 Complete Ans
Nt2009 Complete Ansvora kun
 

Plus de vora kun (20)

NTstep3round2 9_jan2554
NTstep3round2 9_jan2554NTstep3round2 9_jan2554
NTstep3round2 9_jan2554
 
Osce examination si116
Osce examination si116Osce examination si116
Osce examination si116
 
ประชุมวิชาการ ศิริราช 53
ประชุมวิชาการ ศิริราช 53ประชุมวิชาการ ศิริราช 53
ประชุมวิชาการ ศิริราช 53
 
ประชุมวิชาการ ศิริราช 52
ประชุมวิชาการ ศิริราช 52ประชุมวิชาการ ศิริราช 52
ประชุมวิชาการ ศิริราช 52
 
Nt2553step3round1 28NOV2553
Nt2553step3round1 28NOV2553Nt2553step3round1 28NOV2553
Nt2553step3round1 28NOV2553
 
Osce ศรว ครั้งที่สอง 10jan53
Osce ศรว ครั้งที่สอง 10jan53Osce ศรว ครั้งที่สอง 10jan53
Osce ศรว ครั้งที่สอง 10jan53
 
Osce คณะ si 115
Osce คณะ si 115Osce คณะ si 115
Osce คณะ si 115
 
Osce ศรว ครั้งแรก dec52
Osce ศรว ครั้งแรก dec52Osce ศรว ครั้งแรก dec52
Osce ศรว ครั้งแรก dec52
 
Thai Osteoporosis guideline 2553
Thai Osteoporosis guideline 2553Thai Osteoporosis guideline 2553
Thai Osteoporosis guideline 2553
 
ortho 05 common rheumatic dx rx
ortho 05 common rheumatic dx rxortho 05 common rheumatic dx rx
ortho 05 common rheumatic dx rx
 
ortho 01 management of open fracture-update by kk 31052010
ortho 01 management of open fracture-update by kk 31052010ortho 01 management of open fracture-update by kk 31052010
ortho 01 management of open fracture-update by kk 31052010
 
ortho 04 drugs in orthopaedic (principle & common use)
ortho 04 drugs in orthopaedic (principle & common use)ortho 04 drugs in orthopaedic (principle & common use)
ortho 04 drugs in orthopaedic (principle & common use)
 
ortho 03 principle of closed reduction in fracture and dislocation
ortho 03 principle of closed reduction in fracture and dislocationortho 03 principle of closed reduction in fracture and dislocation
ortho 03 principle of closed reduction in fracture and dislocation
 
หัตถการที่จำเป็นทางสูติ
หัตถการที่จำเป็นทางสูติหัตถการที่จำเป็นทางสูติ
หัตถการที่จำเป็นทางสูติ
 
SWU CXR interpretation
SWU  CXR interpretationSWU  CXR interpretation
SWU CXR interpretation
 
Step3 Tutorial by SWU book1
Step3 Tutorial by SWU book1Step3 Tutorial by SWU book1
Step3 Tutorial by SWU book1
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
 
ศรว 51 By Cmu
ศรว 51 By Cmuศรว 51 By Cmu
ศรว 51 By Cmu
 
ศรว 51 ANS By Cmu
ศรว 51 ANS By Cmuศรว 51 ANS By Cmu
ศรว 51 ANS By Cmu
 
Nt2009 Complete Ans
Nt2009 Complete AnsNt2009 Complete Ans
Nt2009 Complete Ans
 

Dernier

Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfErwinPantujan2
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for BeginnersSabitha Banu
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptxmary850239
 
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYKayeClaireEstoconing
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfVanessa Camilleri
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfTechSoup
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Celine George
 
Food processing presentation for bsc agriculture hons
Food processing presentation for bsc agriculture honsFood processing presentation for bsc agriculture hons
Food processing presentation for bsc agriculture honsManeerUddin
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxCarlos105
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parentsnavabharathschool99
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxAnupkumar Sharma
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...JhezDiaz1
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONHumphrey A Beña
 

Dernier (20)

Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
 
Full Stack Web Development Course for Beginners
Full Stack Web Development Course  for BeginnersFull Stack Web Development Course  for Beginners
Full Stack Web Development Course for Beginners
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx
 
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
ICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdfICS2208 Lecture6 Notes for SL spaces.pdf
ICS2208 Lecture6 Notes for SL spaces.pdf
 
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptxLEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
LEFT_ON_C'N_ PRELIMS_EL_DORADO_2024.pptx
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
 
Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17Field Attribute Index Feature in Odoo 17
Field Attribute Index Feature in Odoo 17
 
Food processing presentation for bsc agriculture hons
Food processing presentation for bsc agriculture honsFood processing presentation for bsc agriculture hons
Food processing presentation for bsc agriculture hons
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptxBarangay Council for the Protection of Children (BCPC) Orientation.pptx
Barangay Council for the Protection of Children (BCPC) Orientation.pptx
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parents
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
 

Tutorial national board 2010 Nephrology

Notes de l'éditeur

  1. อธิบายเรื่อง ค่า Cr ที่ไม่เท่ากันในแต่ละคนขึ้นกับ Muscle Mass
  2. อธิบายเรื่อง ค่า Cr ที่ไม่เท่ากันในแต่ละคนขึ้นกับ Muscle Mass